SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
暂无分享，去创建一个
A. Kelleher | G. Dore | V. Sintchenko | M. Hoffmann | S. Turville | A. Ospina Stella | V. Hoad | D. Christ | F. Brilot | I. Gosbell | W. Rawlinson | G. Matthews | A. Aggarwal | D. Irving | Sonia R. Isaacs | Stefan Pöhlman | G. Walker | A. Stella | F. Tea | David Ross Darley | Deepti Pilli | D. Vitale | V. Merheb | Fiona X. Z. Lee | P. Cunningham | C. Fichter | David A. Brown | V. Mathivanan | O. Mazigi | R. Rockett | D. Pilli | Sonia R Isaacs | Stefan Pöhlmann | Iain B. Gosbell | Vennila Mathivanan | Ohan Mazigi | Christina Fichter | Dominic E. Dwyer | D. Darley | Markus Hoffman | Rebeca Rockett | Veronica C. Hoad